Neurologists are thinking about Biogen’s newly approved Alzheimer’s drug, but so far it’s mostly just that—thoughts. While almost 90% of neurologists are moderately or highly aware of Aduhelm, only 3% have written prescriptions so far, according to Spherix Global Insights latest data. Even more concerning? Only about one fourth (27%) plan to prescribe the drug in… Read More »
Having HIV is not an independent risk factor for severe COVID-19 and death amongst patients hospitalised with COVID-19, according to a Zambian study published in the Morbidity and Mortality Weekly Report. However, patients with more severe HIV infection are more likely to develop severe COVID-19 or die of COVID-19 compared to those without complications. “This… Read More »
A study looking at peripheral neuropathy in people living with HIV has found links to both known and new variables including older age, longer duration of HIV infection, exposure to neurotoxic antiretrovirals and other chronic conditions. Dr Wei Tu’s research team at the University of Alberta used machine learning to improve data analysis. They found… Read More »
In the three months since Johnson & Johnson’s COVID-19 vaccine received emergency use authorization from the U.S. Food and Drug Administration, more than 10 million Americans have received the vaccine, according to the Centers for Disease Control and Prevention. The single-shot viral vector vaccine — developed in collaboration with Beth Israel Deaconess Medical Center (BIDMC)… Read More »
LONDON — Another potentially life-saving treatment for hospitalized Covid-19 patients has been discovered by researchers at the University of Oxford. The British study — part of the wider Recovery trial investigating various possible treatments for people hospitalized with coronavirus — found that an antibody combination made by Regeneron reduces the risk of death when given to… Read More »